Lv5
1210 积分 2025-02-13 加入
Tumour-specific STING agonist synthesis via a two-component prodrug system
25天前
已完结
Structure-based classification predicts drug response in EGFR-mutant NSCLC
1个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
1个月前
已完结
PD-1 Blockers
1个月前
已完结
An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer
1个月前
已完结
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction
2个月前
已完结
Things I miss about civilization
2个月前
已完结
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
2个月前
已完结
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
2个月前
已完结
EAI045: The fourth-generation EGFR inhibitor overcoming T790M and C797S resistance
2个月前
已完结
皖公网安备34019202002308
